Psoriatic Arthritis (PsA) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Powered by 
All the vital news, analysis, and commentary curated by our industry experts.
Psoriatic Arthritis (PsA) Marketed and Pipeline Drugs Report Overview
PsA is a chronic immune-mediated arthritis that typically affects the large joints, including those of the lower extremities, the distal joints of the fingers and toes, the back, and the sacroiliac joints of the pelvis. Clinical diagnosis and assessment of PsA involve a combination of patient history, physical examination, laboratory tests, and imaging studies. The goal of diagnosis and assessment is to identify the presence and extent of joint involvement, assess disease activity and severity, and monitor response to treatment over time.
| Key Mechanisms of Action (Marketed) | Receptor Agonist, Enzyme Inhibitor, Biological Factor Inhibitor, Receptor Antagonist, Protein and Peptide Inhibitor, Protein and Peptide Activator, Ion Channel Blocker, And Genes, Nucleic Acids & Related Components Inhibitor |
| Key Routes of Administration | Oral, Topical, Injection, Inhalation, and Suppository |
| Key Molecule Type | Small Molecule and Biologics |
| Key Mechanisms of Action (Pipeline) | Biological Factor Inhibitor, Enzyme Inhibitor, Protein and Peptide Inhibitor, Receptor Antagonist, and Receptor Agonist |
| Key Routes of Administration | Topical, Oral, Injection, Inhalation and Suppository |
| Key Molecule Types | Small Molecule, Biologic, and Oligonucleotide |
| Top Sponsors (Marketed and Pipeline Drugs) | Janssen, AbbVie, Amgen, Pfizer, Novartis, Bristol Myers Squibb, BIOCAD, and ACELYRIN among others. |
The PsA marketed and pipeline drugs market research offers a competitive landscape combining data from the pharma intelligence center with in-house analyst expertise to provide a competitive assessment of the disease marketplace. This report provides a data-driven overview of the current and future competitive landscape in PsA therapeutics.
Psoriatic Arthritis Marketed Drugs Segmentation by Mechanism of Action
The key mechanisms of action for PsA-marketed drugs are receptor agonist, enzyme inhibitor, biological factor inhibitor, receptor antagonist, protein and peptide inhibitor, protein and peptide activator, ion channel blocker, and genes, nucleic acids & related components inhibitor. The most prominent mechanism of action for most marketed drugs for PsA is receptor agonists.
Psoriatic Arthritis Marketed Drugs Analysis by MoA, 2023 (%)
For more MoA insights into Psoriatic Arthritis marketed drugs, download a free report sample
Psoriatic Arthritis Marketed Drugs Segmentation by Routes of Administration
The key routes of administration for Psoriatic Arthritis marketed drugs are oral, topical, injection, inhalation, and suppository. Most marketed drugs for PsA are oral therapies, followed by injection.
Psoriatic Arthritis Marketed Drugs Analysis by RoA, 2023 (%)
For more RoA insights into the PsA marketed drugs, download a free report sample
Psoriatic Arthritis Marketed Drugs Segmentation by Molecule Type
The key molecule types in the PsA marketed drugs market are small molecule and biologics. Majority of the marketed drugs in the PsA market fall under the small molecule category.
Psoriatic Arthritis Marketed Drugs Analysis by Molecule Type, 2023 (%)
For more molecule type insights into the PsA marketed drugs, download a free report sample
Psoriatic Arthritis Pipeline Drugs Segmentation by Mechanisms of Action
The key mechanisms of action for PsA pipeline drugs are biological factor inhibitor, enzyme inhibitor, protein and peptide inhibitor, receptor antagonist, and receptor agonist. Most of the PsA pipeline drugs are biological factor inhibitor.
Psoriatic Arthritis Pipeline Drugs Analysis by MoA, 2023 (%)
For more MoA insights into the PsA pipeline drugs market, download a free report sample
Psoriatic Arthritis Pipeline Drugs Segmentation by Routes of Administration
The key routes of administration for Psoriatic Arthritis pipeline drugs are injection, oral, and topical. The pipeline drugs for PsA are mostly by injection, followed by oral and topical.
Psoriatic Arthritis Pipeline Drugs Analysis by RoA, 2023 (%)
For more RoA insights into the PsA pipeline drugs market, download a free report sample
Psoriatic Arthritis Pipeline Drugs Segmentation by Molecule Type
Most of the pipeline drugs for PsA are biologics, followed by small molecule.
Psoriatic Arthritis Pipeline Drugs Analysis by Molecule Types, 2023 (%)
For more molecule type insights into the PsA pipeline drugs market, download a free report sample
Top Sponsors in the PsA Marketed and Pipeline Drugs Market
Some of the top sponsors in the PsA marketed and pipeline drugs market are Janssen, AbbVie, Amgen, Pfizer, Novartis, Bristol Myers Squibb, BIOCAD, and ACELYRIN among others.
Segments Covered in the Report
PsA Marketed Drugs Mechanisms of Action Outlook (Number of Drugs, 2023)
- Receptor Agonist
- Enzyme Inhibitor
- Biological Factor Inhibitor
- Receptor Antagonist
- Protein And Peptide Inhibitor
- Protein And Peptide Activator
- Ion Channel Blocker
- Genes, Nucleic Acids & Related Components Inhibitor
PsA Marketed Drugs Routes of Administration Outlook (Number of Drugs, 2023)
- Oral
- Topical
- Injection
- Inhalation
- Suppository
PsA Pipeline Drugs Mechanisms of Action Outlook (Number of Drugs, 2023)
- Biological Factor Inhibitor
- Enzyme Inhibitor
- Protein And Peptide Inhibitor
- Receptor Antagonist
- Receptor Agonist
PsA Pipeline Drugs Routes of Administration Outlook (Number of Drugs, 2023)
- Topical
- Oral
- Injection
PsA Pipeline Drugs Molecule Types Outlook (Number of Drugs, 2023)
- Small Molecule
- Biologic
Scope
GlobalData’s Psoriatic Arthritis Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape combines data from the Pharma Intelligence Center with in-house analyst expertise to provide a competitive assessment of the disease marketplace.
Components of the report include:
- Disease Landscape
- Disease Overview
- Epidemiology Overview
- Treatment Overview
- Marketed Products Assessment
- Breakdown by Mechanism of Action, Molecule Type, Route of Administration
- Product Profiles with Sales Forecast
- Pricing and Reimbursement Assessment
- Annual Therapy Cost
- Time to Pricing and Time to Reimbursement
- Pipeline Assessment
- Breakdown by Development Stage, Mechanism of Action, Molecule Type, Route of Administration
- Product Profiles with Sales Forecast
- Late-to-mid-stage Pipeline Drugs
- Phase Transition Success Rate and Likelihood of Approval
- Clinical Trials Assessment
- Breakdown of Trials by Phase, Status, Virtual Components, Sponsors, Geography, and Endpoint Status
- Enrolment Analytics, Site Analytics, Feasibility Analysis
- Deals Landscape
- Mergers, Acquisitions, and Strategic Alliances by Region
- Overview of Recent Deals
- Commercial Assessment
- Key Market Players
- Future Market Catalysts
Reasons to Buy
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the AC market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global AC market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
Amgen
Bristol-Myers Squibb
Celgene
Eli Lilly
Johnson & Johnson
Novartis
Pfizer
UCB
Table of Contents
Frequently asked questions
-
Which is the main mechanism of action for PsA marketed drugs in 2023?
The majority of the drugs in the PsA treatment landscape comprise molecules mediated by receptor agonists, followed by therapies that are enzyme inhibitors.
-
What is the main route of administration for PsA marketed drugs?
Most marketed drugs for PsA are oral therapies.
-
What is the main mechanism of action for PsA pipeline drugs?
The majority of PsA pipeline drugs are biological factor inhibitors, followed by enzyme inhibitors.
-
What is the main route of administration for PsA pipeline drugs?
Most pipeline drugs for PsA utilize the intravenous route of administration, followed by those utilizing the oral route of administration
-
What is the main molecule type for PsA pipeline drugs?
The PsA pipeline mostly comprises biologics, followed by small molecules.
-
Who are the top sponsors for PsA marketed and pipeline drugs market?
Some of the top sponsors in the PsA marketed and pipeline drugs market are Janssen, AbbVie, Amgen, Pfizer, Novartis, Bristol Myers Squibb, BIOCAD, and ACELYRIN among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.
Sample Report
Psoriatic Arthritis (PsA) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:
- Assess the relevance of the report
- Evaluate the quality of the report
- Justify the cost
Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.
Related reports
View more Psoriatic Arthritis reports